Laboratory Centrifuge Market - Growth, Trends, and Forecasts (2023 - 2028)

Laboratory Centrifuge Market - Growth, Trends, and Forecasts (2023 - 2028)

The laboratory centrifuge market is expected to register a CAGR of 5.0% over the forecast period.

The large patient pool of COVID-19, along with the possible shortage of laboratory centrifuges, has fuelled the growth of the laboratory centrifuges market. For instance, an article published by the NCBI in February 2022 reported that during the COVID-19 pandemic, the demand for centrifuges significantly increased to separate the components of saliva for coronavirus detection. However, in the current scenario, it is anticipated that the demand for laboratory centrifuges may stabilize compared to the beginning of the pandemic. Still, with the emergence of other SARS-CoV-2 strains, the demand for centrifuges may increase over the studied market period.

The factors driving the growth of the studied market are the high prevalence of diseases, increasing investment in R&D activity, and technological advancements. Centrifugation is mainly used in the diagnosis of certain infectious diseases like HIV. Centrifugation improves the detection of HIV-1 p24 antigen in plasma from children born to mothers infected with HIV-1. The rising cases of HIV reported globally are expected to increase the demand for centrifuges. For instance, in 2022, UNAIDS reported that globally, 38.4 million people were living with HIV in the year 2021 and 85% of these people get diagnosed themselves. Since the centrifuge is also employed in the separation of pathogens and parasites in biological fluids, so the high incidence of HIV may increase the demand for centrifuges for sample diagnosis and thus be expected to drive the growth of the studied market.

Moreover, the increasing investment in pharmaceutical and biotechnology R&D sectors is also contributing to the growth of the studied market. For instance, in May 2022, National Center for Health Statistics (NCHS) reported that globally USD 7,847 million were invested in biotechnology R&D in the year 2021 and is expected to reach USD 8,142 million by the end of 2022. The increase in R&D investment will lead to the development of new drugs, and the centrifuge machinery is suited for separating amino acids, benzoic acid, benzene, sulfur, calcium hypochloride, hexachlorocyclohexane, insulin, penicillin, starch, and various other intermediate products used in drug development. Thus, increasing investments in the biotechnology sector are leading to increasing R&D activity, which is increasing the demand for laboratory centrifuges, thereby driving the growth of the studied market.

In recent years, certain key players in the laboratory centrifuges market have launched centrifuges integrated with advanced rotors and other features. For instance, in April 2021, Eppendorf AG (Germany) launched its Multipurpose Centrifuge 5910 Ri, which offers advanced features to enhance and simplify centrifugation. This centrifuge is the successor to the popular Centrifuge 5910 R. It offers an innovative touchscreen interface, an optional connection to the new VisioNize Digital Lab Suite for remote monitoring, and the unique Universal rotor, which allows 50 mL conical tubes, plates, and 250 mL bottles without the need to change the rotor, rotor buckets, or adapters. Thus, the new centrifuge launches are incorporated with better technology, delivering better results and thereby driving the growth of the studied market.

While the market is expected to perform well, the high equipment cost and long equipment lifespans may slow down its development.

Benchtop centrifuges are engineered with benchtops to operate the product safely in the closed chamber. These are simple to operate and are accommodated with the auto-lock system to quickly exchange rotors with one hand for application versatility and maximum throughput. The design of these centrifuge minimizes potential pinch points while opening and closing the lid, and a motorized lid latch provides extra protection. Benchtop centrifuge is expected to witness significant growth over the forecast period owing to its cost-effective, easy-to-use, and versatile nature for chromatography, sedimentation, and filtration of samples.

The ease and compatibility of benchtop centrifuges are driving the growth of this segment. For instance, an article published by the National Library of Medicine in July 2021 reported that benchtop centrifuges are preferred for laboratory purposes as they require limited space and are used in various applications. The article also reported the design, small samples, fast processing, and high RCF features make this centrifuge widely used and thus contribute to the growth of this segment.

Furthermore, new product launches are also fueling the growth of this segment. For instance, in June 2021, KUBOTA Corporation (Japan) launched the Benchtop Centrifuge USD 500T and Floor-Standing Refrigerated Centrifuge S500FR.

North America is expected to witness significant growth over the forecast period owing to the increasing prevalence of diseases and rising awareness about diagnosis and treatment. Also, product launches, mergers, partnerships, and acquisitions due to the presence of the key market players further fuel the growth of this market in the region.

The high incidence of tuberculosis (TB) reported in North American countries is increasing the use of centrifuges for diagnosing the samples. Optimal tuberculosis testing usually involves sputum centrifugation followed by broth culture, and thus the high number of TB cases is driving the growth of the market in the country. For instance, an article published by the NCBI in November 2022 reported that there were 77 active cases of tuberculosis diagnosed in Nunavut (Canada) in 2021, more than twice as many as the year before.

Similarly, in May 2022, the Government of Mexico reported that more than 90 thousand people were diagnosed with HIV during 2020-2021.

Moreover, technological developments and partnerships, mergers, acquisitions, and new product launches are driving the growth of this market in the region. For instance, in June 2021, Quest Diagnostics completed the acquisition of Mercy’s Outreach Laboratory Services business. The transaction aims to increase access to innovative, high-quality, and affordable laboratory services to provide reasonable patient care throughout the Midwest. Upon completing the acquisition, Quest will gain immediate access to a broader network of healthcare professionals in Kansas, Arkansas, Missouri, and Oklahoma.

The laboratory centrifuge market is fragmented and consists of several major players. In terms of market share, some of the prominent market participants are Andreas Hettich GmbH & Co. KG, Danaher Corporation (Beckman Coulter, Inc.), Eppendorf AG, Thermo Fisher Scientific Inc., HERMLE Labortechnik GmbH, KUBOTA Corporation, Sartorius AG, NuAire, Sigma Laborzentrifugen GmbH, and Qiagen NV.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support